01/02/2025, 05:50 AM UTC
不适合收益投资者的abrdn医疗投资者基金（HQH）HQH: Not For Income Investors
1、abrdn医疗投资者基金因与收益投资和管理的分配计划不匹配而被评为‘卖出’；2、该基金的表现不及纳斯达克生物技术指数和iShares生物技术ETF，表明其无法与更有效的税收替代品相比产生alpha；3、该基金的高收益不可持续，依赖于资本收益，并可能迫使提前销售，这对收益导向的投资者来说并不合适。1. The abrdn Healthcare Investors fund is rated 'sell' due to its mismatch with income investing and managed distribution plans; 2. The fund has underperformed the Nasdaq Biotechnology Index and iShares Biotechnology ETF, indicating its inability to generate alpha compared to more tax-efficient alternatives; 3. The fund's high yield is unsustainable, relying on capital gains and potentially forcing premature sales, which is not suitable for income-oriented investors.---
本文由大语言模型（LLM）生成，旨在为读者提供半导体新闻内容的知识扩展（Beta）。
